Immupharma and W Resources
Justin Waite
Vox Markets Podcast with Justin Waite
14:53, 2nd December 2019

Vox Media Player

DYOR Disclaimer

If you find this podcast useful please give it a rating and review on iTunes by clicking here

Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here:

On today's Vox Markets Podcast: Immupharma and W Resources

Tim McCarthy, Chairman of ImmuPharma (IMM) FOLLOW discusses their licence agreement for Lupuzor with Avion in US.

ImmuPharma PLC (AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The company portfolio includes novel peptide therapeutics for autoimmune diseases, metabolic diseases and cancer. The lead program, Lupuzor™, is a first-in class autophagy immunomodulator which is in Phase III for the treatment of lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.

Michael Masterman, Chairman of W Resources (WRES) FOLLOW provides an update on their La Parrilla Tungsten and Tin mine in Spain.

W Resources strategy is to build a European mining company focussed on delivering long term production of tungsten, a key strategic metal with strong market fundamentals. With a focus on building a world class tungsten company, its flagship project, La Parrilla in Spain is one of the world’s largest tungsten mines, which is under development and funded by BlackRock.

(Interview starts at 13 minutes 53 seconds)

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Login or register to post comments

Recent Articles